Metraipolis › archive › dc_ffde6ee5ba3d

Advances in the clinical application of bispecific antibodies in cancer therapy — Europe PMC PMID:41476945

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41476945
DOI
10.1016/j.isci.2025.114203
License (as archived)
solo-consultazione
Archived
2026-11-08T06:55:42.990Z
SHA-256 of the archived text
952bc993f424d3186c3cef589fc0948dd43d08dd86f14db950b9575e5a4d83ed
Stable URL of this page
https://metraipolis.com/documento/dc_ffde6ee5ba3d

How to cite

Advances in the clinical application of bispecific antibodies in cancer therapy — Europe PMC PMID:41476945 — Europe PMC (en), https://europepmc.org/article/MED/41476945 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffde6ee5ba3d (Metraipolis archive dc_ffde6ee5ba3d, sha256 952bc993f424d3186c3cef589fc0948dd43d08dd86f14db950b9575e5a4d83ed)
BibTeX
@misc{dcffde6ee5ba3d,
  title = {Advances in the clinical application of bispecific antibodies in cancer therapy — Europe PMC PMID:41476945},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41476945},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffde6ee5ba3d; sha256 952bc993f424d3186c3cef589fc0948dd43d08dd86f14db950b9575e5a4d83ed},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41476945. Agents can read the archived copy with the MCP tool read_document.